Outlook Therapeutics Inc (NASDAQ:OTLK)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - OTLK

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - OTLK

  • Market Cap$94.120m
  • SymbolNASDAQ:OTLK
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS69012T2069

Company Profile

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology.

Latest OTLK news

Currently there for this company. Visit our news hub for other news .